ResMed Inc. (RSMDF) Free cash flow 2017–2026
ResMed Inc. (RSMDF) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$1.6BFY2026 · since FY2017: $351.8M → $1.6B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $1.6B | -0.7% |
| FY2025 | $1.7B | +27.6% |
| FY2024 | $1.3B | +126.9% |
| FY2023 | $573.6M | +165.2% |
| FY2022 | $216.3M | -65.9% |
| FY2021 | $634.0M | -10.3% |
| FY2020 | $706.9M | +81.1% |
| FY2019 | $390.3M | -11.8% |
| FY2018 | $442.4M | +25.8% |
| FY2017 | $351.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More RSMDF financial trends
RSMDF RevenueRSMDF Net incomeRSMDF Net marginRSMDF Gross profitRSMDF Gross marginRSMDF Operating incomeRSMDF Operating marginRSMDF Operating cash flowRSMDF Capital expendituresRSMDF Return on equityRSMDF Stock buybacksRSMDF Dividends paidRSMDF Total assetsRSMDF Total liabilitiesRSMDF Shareholders’ equityRSMDF overview →